Serenus Biotherapeutics' Corporate Minority Round

Serenus Biotherapeutics raised a round of funding on March 03, 2015. Investors include Malin Corporation.

Serenus Biotherapeutics is a privately held specialty biopharmaceutical company that specializes in late-stage drug development, in-licensing, registering, and commercializing therapies approved in th…

Articles about Serenus Biotherapeutics' Corporate Minority Round: